JPMorgan raised the firm’s price target on Amrize (AMRZ) to $70 from $60 and keeps an Overweight rating on the shares. The firm says the company’s guidance beat expectations. It upped estimates post the earnings print.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRZ:
- Amrize Unveils EVERtect High-Performance Concrete Line for North America
- Amrize price target raised to $76 from $67 at Citi
- Amrize price target raised to CHF 54 from CHF 47 at Deutsche Bank
- Amrize price target raised to $75 from $60 at Truist
- Amrize price target raised to $70 from $64 at Oppenheimer